ORGO: Organogenesis Holdings Inc. Stock

by  •  • Comments Off on ORGO: Organogenesis Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 535.21
Enterprise Value ($M) 587.98
Book Value ($M) 385.32
Book Value / Share 3.04
Price / Book 1.40
NCAV ($M) 173.37
NCAV / Share 1.37
Price / NCAV 3.09

Profitability (mra)
Return on Invested Capital (ROIC) 0.00
Return on Assets (ROA) 0.00
Return on Equity (ROE) 0.00

Liquidity (mrq)
Quick Ratio 3.35
Current Ratio 3.69

Balance Sheet (mrq) ($M)
Current Assets 285.94
Assets 497.89
Liabilities 112.57
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 482.04
Operating Income 21.52
Net Income 0.86
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 14.21
Cash from Investing -10.03
Cash from Financing 27.64

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-11 13G/A Soleus Capital Master Fund, L.P. 9.90 5.45
01-13 13D/A Ades Alan A. 17.80
11-19 13D Avista Healthcare Partners III, L.P. 18.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 158,708 533,677 29.74
2025-04-16 119,535 873,975 13.68
2025-04-15 178,432 587,214 30.39

(click for more detail)

Similar Companies
ONCO – Onconetix, Inc. ONCY – Oncolytics Biotech Inc.
ONVO – Organovo Holdings, Inc. ORMP – Oramed Pharmaceuticals Inc.
OTLK – Outlook Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io